Therapeutic Asset Ratings
271 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Rintatolimod
Colorectal Cancer
Roswell Park Cancer Institute
P2
CCC
(50)
2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A
Lung Non-Small Cell Carcinoma
Roswell Park Cancer Institute
P1
CCC
(50)
Rintatolimod
Triple-Negative Breast Carcinoma
Roswell Park Cancer Institute
P1/2
CCC
(50)
Rintatolimod
HLA-A2 Positive Cells Present
Roswell Park Cancer Institute
P2
CCC
(48)
Rintatolimod
Colorectal Adenocarcinoma
Roswell Park Cancer Institute
P2
CCC
(48)
Rintatolimod
Microsatellite Stable
Roswell Park Cancer Institute
P2
CCC
(48)
Rintatolimod
Mismatch Repair Proficient
Roswell Park Cancer Institute
P2
CCC
(48)
Rintatolimod
Prostate Adenocarcinoma
Roswell Park Cancer Institute
P2
CCC
(48)
Rintatolimod
Melanoma
Roswell Park Cancer Institute
P2
CCC
(48)
Rintatolimod
Prostate Cancer
Roswell Park Cancer Institute
P2
CCC
(48)
2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A
Locally Advanced Colorectal Carcinoma
Roswell Park Cancer Institute
P1/2
CCC
(48)
2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A
Stage III Colorectal Cancer
Roswell Park Cancer Institute
P1/2
CCC
(48)
Autologous Natural Killer Cell-Like Ctls
Fallopian Tube Cancer
Roswell Park Cancer Institute
P1/2
CCC
(48)
Autologous Natural Killer Cell-Like Ctls
Ovarian Cancer
Roswell Park Cancer Institute
P1/2
CCC
(48)
Autologous Natural Killer Cell-Like Ctls
Fallopian Tube Carcinoma
Roswell Park Cancer Institute
P1/2
CCC
(48)
Autologous Natural Killer Cell-Like Ctls
Ovarian Carcinoma
Roswell Park Cancer Institute
P1/2
CCC
(48)
Autologous Natural Killer Cell-Like Ctls
Primary Peritoneal Carcinoma
Roswell Park Cancer Institute
P1/2
CCC
(48)
Decitabine
Synovial Sarcoma
Roswell Park Cancer Institute
P1/2
CCC
(48)
Decitabine
Castration-Resistant Prostate Carcinoma
Roswell Park Cancer Institute
P1/2
CCC
(48)
Monomethyl Fumarate
Severe Aplastic Anemia
Roswell Park Cancer Institute
P1/2
CCC
(48)
Montanide Isa 51
Head And Neck Squamous Cell Carcinoma
Roswell Park Cancer Institute
P1/2
CCC
(48)
Montanide Isa 51
Skin Squamous Cell Carcinoma
Roswell Park Cancer Institute
P1/2
CCC
(48)
Rapamycin
Aplastic Anemia
Roswell Park Cancer Institute
P1/2
CCC
(48)
Recombinant Human EGF-rP64K
Head And Neck Squamous Cell Carcinoma
Roswell Park Cancer Institute
P1/2
CCC
(48)
Recombinant Human EGF-rP64K
Skin Squamous Cell Carcinoma
Roswell Park Cancer Institute
P1/2
CCC
(48)
Showing 176 to 200 of 271 assets
Previous
Page 8 of 11
Next